HSBC Holdings’s iShares Biotechnology ETF IBB Stock Holding History

HSBC Holdings’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-22,600	Closed	-$3.4M	–	2919
2020 Q4	$3.4M	Sell	22,600 -1,100	-5%	-$157K	﹤0.01%	1168
2020 Q3	$3.23M	Hold	23,700	–	–	0.01%	1115
2020 Q2	$3.24M	Buy	23,700 +18,000	+316%	+$2.29M	0.01%	1007
2020 Q1	$614K	Buy	+5,700	New	+$656K	﹤0.01%	1681
2019 Q2	–	Sell	-200	Closed	-$22K	–	2761
2019 Q1	$22K	Sell	200 -59,800	-100%	-$6.56M	﹤0.01%	2679
2018 Q4	$5.79M	Hold	60,000	–	–	0.01%	1043
2018 Q3	$7.32M	Hold	60,000	–	–	0.01%	980
2018 Q2	$6.59M	Hold	60,000	–	–	0.01%	987
2018 Q1	$6.4M	Buy	+60,000	New	+$6.65M	0.01%	1017
2017 Q4	–	Sell	-600	Closed	-$67K	–	2207
2017 Q3	$67K	Buy	+600	New	+$64.1K	﹤0.01%	2245
2017 Q1	–	Sell	-45,000	Closed	-$3.98M	–	2330
2016 Q4	$3.98M	Hold	45,000	–	–	0.01%	1001
2016 Q3	$4.34M	Hold	45,000	–	–	0.01%	944
2016 Q2	$3.86M	Hold	45,000	–	–	0.01%	994
2016 Q1	$3.91M	Hold	45,000	–	–	0.01%	961
2015 Q4	$5.08M	Buy	+45,000	New	+$4.88M	0.01%	935

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

HSBC Holdings's IBB Position: Q2 2026 in Review

HSBC Holdings reduced its iShares Biotechnology ETF (IBB) stake by 57% in Q2 2026, selling an estimated $357K and leaving 1,541 shares worth $293K. The position accounts for ﹤0.01% of the portfolio, ranked #2528.

HSBC Holdings first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $13M in Q4 2017. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

HSBC Holdings held 1,541 shares of iShares Biotechnology ETF worth $293K as of Q2 2026.
HSBC Holdings sold 2,076 iShares Biotechnology ETF shares in Q2 2026, an estimated $357K.
iShares Biotechnology ETF made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2528 holding.
HSBC Holdings first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
HSBC Holdings's iShares Biotechnology ETF position peaked at $13M in Q4 2017.
960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.